Amador Bioscience vs Aragen Life Sciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/amadorbioscience/aragen

Category	Amador Bioscience	Aragen Life Sciences
Listed site	cro	cro
Summary	Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe.	Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Services	Bioanalysis Ligand-Binding Bioanalysis (Large Molecule) LC-MS Bioanalysis (Small Molecule) Immunogenicity Assays (ADA / NAb) Flow Cytometry Services Biomarker Assays Biostatistics & Statistical Programming Translational Research Regulatory Affairs Clinical Trial Services Clinical Operations Phase IV / Post-Marketing	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Translational Research US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Regulatory Affairs
Modalities	Antibody-Drug Conjugate (ADC) Oligonucleotide Peptide Small Molecule Cell Therapy Gene Therapy mRNA Vaccine Biologics (Other)	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Oligonucleotide mRNA Cell Therapy Gene Therapy Peptide Vaccine
Indications	Data not yet provided.	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health
Locations	California, California, United States Maryland, Maryland, United States Michigan, Michigan, United States Belgium, Belgium Hangzhou, Hangzhou, China Shanghai, Shanghai, China Beijing, Beijing, China	Global Headquarters, Hyderabad, Telangana, India R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Hyderabad, Telangana, India Manufacturing Campus, Visakhapatnam, Andhra Pradesh, India R&D Campus, Bengaluru, Karnataka, India Biosafety Solutions, Pune, Maharashtra, India Regional Office, New Delhi, Delhi, India Sales Office, Tokyo, Japan Sales Office, Seoul, South Korea Sales Office, Cambridge, Massachusetts, USA R&D Campus, Morgan Hill, California, USA Sales Office, Utrecht, Netherlands Sales Office, Milan, Italy Sales Office, South Korea Global Headquarters & R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Pune, Maharashtra, India R&D Campus, New Delhi, Delhi, India Sales Office, New Jersey, New Jersey, USA Global Headquarters, R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Mallapur, Hyderabad, India
Certifications	Data not yet provided.	USFDA · Identifier: EIR for Nacharam Unit 1
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.